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Patients with AIDS often show active infections by viruses other than human immunodeficiency virus (HIV), such as cytomegalovirus, herpes simplex, and herpes zoster (28, 40) . Retroviruses other than HIV may also be viral cofactors, as antibodies for human T-cell lymphotropic virus type I (HTLV-I) and/or HTLV-II are occasionally found in patients with AIDS, particularly in intravenous drug abusers (19) . In this article, we describe a retrovirus isolated from a patient with AIDS and lymphoma which is virtually identical to a prototype simian type D retrovirus. Simian type D retroviruses are highly prevalent in rhesus macaques in U.S. primate colonies and can cause an AIDS-like syndrome in the infected animals (16, 27) . There have been several related type D serotypes isolated from rhesus monkeys in the last 10 years. The first type D isolate, however, was obtained from a breast carcinoma of a female rhesus monkey in 1970 (4) . This virus isolate, Mason-Pfizer monkey virus (MPMV), when inoculated into juvenile rhesus macaques, causes a wasting disease accompanied by lymphoid depletion, thymic atrophy, and opportunistic infections (2, 14) . This syndrome, simian AIDS, is caused by several different types of type D virus isolates as well as by the lentiviral simian immunodeficiency viruses (1, 5, 6, 16, 26, 27, 33) . Since its initial isolation, MPMV has rarely been reisolated from macaques (2) . Related type D viruses, such as simian retrovirus-1 (SRV-1), SRV-2, and D/New England, are currently associated with macaques having simian AIDS (16) .
Type D retroviruses, apparently of simian origin, have never been convincingly associated with humans. Extensive serological surveys in the past failed to show evidence of human type D retrovirus infection (3, 17) . However, a number of isolated reports have appeared over the last 15 years describing serological reactivity of human sera to type D virus antigens (22, 34, 35, 44, 45) . In addition, a number of established human cell lines producing type D retroviruses have been described (11, 16, 24, 25, 37, 47) . Several of these * Corresponding author.
cell line-derived type D isolates have been physically mapped with restriction endonucleases, and at least two of them have been molecularly cloned and sequenced. One cloned isolate was closely related to SRV-1 (30) , and the other was very similar to the squirrel monkey retrovirus (36) . Two of the physically mapped isolates appeared to be identical to MPMV (46) . It was assumed that these viruses and many of the other isolates from established lines were a result of prior laboratory contamination (30, 47) .
In this article, we describe a type D retrovirus virtually identical to MPMV that was produced by two early-passage B-cell lymphoma lines established from a patient with AIDSrelated lymphomas. We provide evidence that the isolated virus was not a laboratory contaminant but was derived from the original patient. Histological examination of the patient's lymphoma tissue showed that his neoplastic B cells clearly formed syncytia, unprecedented in human B-cell lymphomas but quite characteristic of type D virus infections of the Raji Burkitt's lymphoma B-cell line in vitro (5) . Polymerase chain reaction (PCR) analysis of the patient's diagnostic bone marrow biopsy specimen with MPMV-specific primers indicated that MPMV DNA sequences were present in the biopsy material. Finally, the patient's serum demonstrated a strong reactivity to MPMV antigens by both immunoblot and immunoprecipitation analyses. These data are consistent with a type D retrovirus infection of the reported patient. However, the role of the virus in the disease state of this individual remains unclear. (39) . The membranes were hybridized to a 32p_ radiolabeled MPMV env DNA fragment or a labeled p278ag fragment generated by the technique of Feinberg and Vogelstein (10) . Hybridizations were carried out at 68°C as described previously (39) . After hybridization, the filters were washed several times with 0.1 x SSC-1% SDS at 50°C (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate).
MATERIALS AND METHODS

Patient
Immunoblot analysis. Immunoblotting was performed essentially as described by Harlow and Lane (20) . Glycerol gradient-purified virus derived from the bone marrow-derived lymphoma cell line was disrupted in 4% SDS-4% 2-mercaptoethanol, heated to 100°C in sample buffer, and electrophoresed on a 12% polyacrylamide-SDS gel. Proteins were electrophoretically transferred to a nitrocellulose membrane. The membrane was rinsed with phosphate-buffered saline, blocked with 5% nonfat dry milk (agitation for 2 h at room temperature) or Megga-Block Ilb (Onasco Biotechnologies), and cut into strips. Individual strips were incubated with various anti-MPMV monoclonal antibodies and polyclonal sera or with human sera from the studied patient, other patients with AIDS, or healthy individuals. Bound antibodies were detected by an alkaline phosphatase-labeled secondary antibody with BCIP-NBT (5-bromo-4-chloro-3-indolylphosphate toluidinium-nitroblue tetrazolium) substrates (Promega Biotec Protoblot System). For the immunoblots shown in Fig. 5 , the secondary antibody used was a nonconjugated goat anti-human immunoglobulin antibody. In addition, the immunoblots were incubated with an alkaline phosphatase-conjugated swine anti-goat immunoglobulin tertiary antibody.
Radioimmunoprecipitation. An in vitro transcription-translation system was used to generate 35S-labeled MPMV major core protein as a substrate for immunoprecipitation assays with selected sera. A plasmid expression vector, pSP73 (Promega Biotec), was engineered so that it expressed the MPMV major core protein, p27, from its T7 promoter. An MPMV plasmid clone, generously supplied by Eric Hunter, was subjected to PCR with primers derived from the 5' and 3' ends of the p27 coding region. The 5' primer had an additional Met codon preceded by a standard eucaryotic translation initiation motif (29) (Fig. 1A, B , and C). Multinucleated giant cells were interspersed among the usual small noncleaved cells characteristic of Burkitt's lymphoma. The presence of syncytia in these tumors in vivo was a distinctly unusual and previously unreported pathologic phenomenon. Our initial hypothesis was that an HIV-1 with altered biological properties had infected the lymphoma cells and caused the observed syncytium formation. In order to isolate a potentially novel HIV variant, two cell lines derived from separate B-cell tumors (bone marrow and kidney) and a lymphoblastoid B-cell line from peripheral blood lymphocytes of this patient were established in culture and were designated RCBM, RCKD, and RCL, respectively. Both Southern blot analysis for immunoglobulin (JH) and T-cell receptor genes and FACS analysis for B-cell and T-cell markers demonstrated these cells to be of B-cell lineage. In addition, cytogenetic analysis of each tumor cell line and analysis of immunoglobulin gene rearrangement suggested that the two lines were of different clonal origin, as they exhibited different chromosome numbers and JH immunoglobulin rearrangement patterns.
Electron microscopic examination of the cell lines RCBM and RCKD revealed intracellular retroviral particles. Further microscopic examination of the virus-containing medium indicated that large numbers of retroviruses (greater than 108 particles per ml of medium) were released by these two lines. The particles in the infected cells were approximately 110 to 120 nm in diameter, and many appeared to be present in intracellular vesicles as well as in extracellular spaces (Fig.   1D ). The presence of intracellular viral particles and the barrel-shaped core morphology sometimes observed in the mature extracellular virions are characteristic of type D retroviruses rather than lentiviruses or type C retroviruses (11) .
Reverse transcriptase assays were performed on gradient fractions of virus purified from the RCBM and RCKD cell lines. Peak enzymatic activity was observed at a gradient density of 1.17 g/ml, indicating that typical retroviral particles were present (43) . The viral reverse transcriptase from purified virions displayed a cation preference for magnesium over manganese, typical of type D retroviruses (11) . The reverse transcriptase also had significantly greater activity in the presence of a poly(rC)-oligo(dG) template-primer combination than with the standard poly(rA)-oligo(dT) templateprimer (Table 1) . These reverse transcriptase activities are in marked contrast to those of HIV-1 and RSV, both of which demonstrate a poly(rA)-oligo(dT) template-primer preference. However, this substrate preference is in agreement with a previous report (21) which showed that MPMV reverse transcriptase had higher activity in the presence of poly(rC)-oligo(dG). None of the retroviruses showed significant activity with a poly(dA)-oligo(dT) template, indicating that contamination by cellular DNA polymerases was not a problem (data not shown). (Fig. 1E ). Syncytia were also evident when the Raji B-cell lymphoma line was infected with the same viral isolates (Fig. 1F) . Syncytium formation in Raji cells has previously been reported to be characteristic of simian type D retroviruses (5) .
Confirmation that the lymphoma cell lines were not in- HIV-1, HTLV-I, and HTLV-II probes (data not shown). PCR amplification with two different sets of HIV-1-specific primers generated no HIV-1-specific DNA fragments whereas HIV-1-infected H9 cells did exhibit the appropriately sized fragments. An anti-HIV-1 p24 monoclonal antibody failed to react with either viral isolate (from RCBM or RCKD) by immunoblot analysis, and an HIV-1 p24 antigen capture assay (Abbott Diagnostic) failed to detect HIV-1 Identification of the AIDS-related lymphoma retrovirus. Since the viral isolates showed no similarity to known human retroviruses, we used a rapid molecular approach to identify them. A previously described PCR-based procedure (32, 41) was adapted that utilizes degenerate oligonucleotide primers derived from two regions in the pol gene (about 100 nucleotides apart) conserved in amino acid sequence among all retroviruses (Fig. 2A) (16, 27) . In Fig. 2B , the alignment of the two sequenced clones with the corresponding region of MPMV and SRV-1 indicates that the clones are 96.6 and 97.4% similar to MPMV and 91.5 and 92.3% similar to SRV-1.
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The identity of the viral isolate as MPMV-related was confirmed by several methods. Southern blot hybridization with MPMV DNA probes and PCR amplification with MPMV-specific primers showed that the genomic DNA of one of the virus producer lines contained at least three MPMV-like proviruses (data not shown). Murine antibodies were generated to the viral isolates from cell lines RCBM and RCKD and used to detect the viral proteins of disrupted virions (from both isolates) by immunoblot analysis (as typified in Fig. 3, lane 1) . Major RCBM and RCKD viral protein bands at 14, 20, 27, and 70 kDa were observed, and these sizes correlate well with the known sizes of major MPMV gag (p14 and p27) and env (gp2O and gp7O) proteins (8) . The RCBM and RCKD viral proteins also reacted strongly with specific antisera to MPMV gag (p27) and env (gp7O) proteins (Fig. 3, lanes 2 and 3) and with antisera to proteins of the closely related simian type D retrovirus SRV-1 (Fig. 3,  lanes 4 and 5) .
The 14-and 27-kDa gag viral proteins of the RCBM isolate were purified and subjected to N-terminal amino acid sequencing. The amino-terminal 20 amino acids of the p14 of the viral isolate were identical to those for p14 of MPMV (42) and SRV-1 (38) ( Table 3) . Sequencing of the 20 aminoterminal residues of p27 showed a match of 19 of 20 amino acids with the MPMV and SRV-1 p27 major core proteins ( Table 3) .
Detection of MPMV-specific DNA sequences in bone marrow. The identification of AIDS-related lymphoma-derived viral isolates highly similar to a prototype simian type D retrovirus raised the possibility that these viruses might be laboratory contaminants. Previous investigators have observed MPMV or MPMV-related viruses in established human cell lines (18, 24, 25, 30, 36, 37, 46, 47) . Although we identified the virus in early passages of the cultured lymphoma cells and our laboratories have never worked with monkeys, simian retroviruses, or known MPMV-infected human cell lines, the possibility of laboratory contamination could only be ruled out by direct demonstration of the virus in the patient from whom the lymphomas were obtained. Unfortunately, by the time the viral isolates had been identified, the patient had died of chemotherapy-resistant lymphoma, and we were limited for our analyses to a small sample of the patient's serum and a Formalin-fixed diagnostic bone marrow biopsy specimen embedded in a paraffin block. The biopsy specimen was prepared for PCR analysis by a published procedure (48) . DNA extracted from this biopsy specimen was subjected to 40 cycles of PCR amplification with MPMV-specific env primers that could distinguish between MPMV and the closely related SRV-1. The PCR products were subjected to agarose gel electrophoresis, blotted onto a nylon membrane, and hybridized to a labeled MPMV env DNA probe under stringent conditions (Fig. 4A) . The patient material and positive controls generated a hybridizing band of approximately 300 bp, the expected size for an MPMV-specific fragment. PCR amplification of DNA from peripheral blood lymphocytes of six normal persons with the MPMV primers failed to generate any MPMVspecific fragments (data not shown). Repeated PCR experiments with the biopsy material (under conditions designed to avoid DNA contamination) generated the 300-bp MPMVspecific band, indicating that the lymphoma that infiltrated the patient's bone marrow was infected with this MPMV-like retrovirus. Southern blot hybridization (under stringent conditions) with the MPMV env probe and subsequent sequence analysis of the PCR-amplified 300-bp fragment derived from the bone marrow biopsy specimen confirmed the identity of the fragment as MPMV-like. Similar PCR analysis of the biopsy material performed with p279'9-specific primers and 30 cycles of amplification showed that only DNA from the virus producer line RCBM and the patient biopsy material generated the expected 700-bp signal (Fig. 4B) .
Reactivity of serum with MPMV antigens. To provide further evidence that the patient was infected with an MPMV-like virus, a serum sample was tested for reactivity to proteins of the MPMV-like viral isolate by immunoblot analysis. The patient's serum sample strongly recognized the two env proteins gp70 and gp2O and the gag proteins p27 and p14 (and possibly p12). Serum samples from 10 patients with AIDS were negative for type D virus antibodies by this immunoblot assay (Fig. 5) . (11, 18, 24, 25, 30, 36, 37, 46, 47) , but these infections were usually ascribed to laboratory contaminations (30, 47) . Other investigators have described MPMVreactive antisera from normal humans (22, 35, 45) and those with AIDS-related or non-AIDS-related lymphadenopathy (34 As far as can be determined, our patient had no contact with monkeys. However, since this individual was severely immunocompromised by infection with HIV-1, it is possible that he acquired this type D retrovirus under conditions in which an individual with a normal immune system would resist such an infection. Alternative possibilities are that (i) the virus was transmitted to the patient simultaneously with HIV-1 or (ii) the virus was present in the individual but caused no symptoms prior to infection by HIV-1. Consistent with the latter possibility are reports that type D retroviruses are endemic in some U.S. primate colonies and appear to be present in many animals in an asymptomatic state (7, 12, 13, 17 (3, 17) .
It is not known whether the MPMV-like retrovirus isolate played a role in the pathogenesis of the patient's depressed immune state. In rhesus macaques, MPMV and related type D retroviruses cause simian AIDS, a disease characterized by immunosuppression (including reduced CD4/CD8 ratios), lymphadenopathy, thymic atrophy, and chronic wasting accompanied by opportunistic infections (16, 27) . In addition, type D primate retroviruses have been associated with lymphomas in infected macaques (23, 31) , a rare disease in these animals (31) 
